SUNWAY(SZ:002469) Xin Lang Cai Jing·2025-10-24 01:48Core Viewpoint - The financial performance and stock trading activity of Sanwei Chemical indicate a stable growth trajectory, with significant increases in revenue and net profit, while the financing and margin trading activities remain at relatively low levels [1][2][3]. Group 1: Financial Performance - For the first half of 2025, Sanwei Chemical achieved operating revenue of 1.249 billion yuan, representing a year-on-year growth of 21.81% [2]. - The net profit attributable to the parent company for the same period was 120 million yuan, showing a year-on-year increase of 42.54% [2]. - Cumulatively, the company has distributed a total of 1.291 billion yuan in dividends since its A-share listing, with 681 million yuan distributed over the past three years [3]. Group 2: Stock Trading Activity - On October 23, Sanwei Chemical's stock price increased by 0.22%, with a trading volume of 65.99 million yuan [1]. - The financing buy amount on the same day was 5.3262 million yuan, while the financing repayment was 6.1604 million yuan, resulting in a net financing buy of -834,200 yuan [1]. - As of October 23, the total balance of margin trading for Sanwei Chemical was 181 million yuan, which accounts for 3.10% of its market capitalization, indicating a low financing balance compared to the past year [1]. Group 3: Shareholder Information - As of June 30, the number of shareholders for Sanwei Chemical was 42,500, a decrease of 17.75% from the previous period [2]. - The average number of circulating shares per shareholder increased by 21.58% to 14,790 shares [2]. - Among the top ten circulating shareholders, Hongli Low Volatility (512890) is the second-largest shareholder with 27.8388 million shares, unchanged from the previous period [3].